Opportunistic Infections in Patients Receiving Daratumumab Regimens for Multiple Myeloma (MM)

被引：2
|
作者：
Burns, Ethan A. [1 ]
Ensor, Joe E. [2 ]
Anand, Kartik [3 ]
Gentille, Cesar [4 ]
Guerrero, Carlo [1 ]
Kieser, Ryan B. [1 ]
Umoru, Godsfavor [5 ]
Shah, Shilpan S. [1 ]
Petkova, Jenny H. [6 ]
Ganguly, Siddhartha [6 ,7 ]
Rice, Lawrence [8 ]
Pingali, Sai Ravi Kiran [1 ]
机构：
[1] Houston Methodist Canc Ctr, Houston, TX USA
[2] Houston Methodist Res Inst, Houston, TX USA
[3] Callahan Canc Ctr, Great Plains Hlth, North Platte, NE USA
[4] Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therap, Stanford, CA 94305 USA
[5] Houston Methodist Hosp, Dept Pharm, Houston, TX 77030 USA
[6] Houston Methodist Hosp, Houston, TX 77030 USA
[7] Ctr Canc, Houston, TX USA
[8] Houston Methodist Hosp, Dept Med, Weill Cornell Med Collage, Houston, TX 77030 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-152068
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4740
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Effect of Intravenous Immunoglobulin on Infections in Multiple Myeloma (MM) Patients Receiving Daratumumab
    Lancman, Guido
    Sastow, Dahniel
    Aslanova, Minira
    Moshier, Erin
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir
    Richard, Shambavi
    Richter, Joshua
    Sanchez, Larysa
    Chari, Ajai
    BLOOD, 2020, 136
  • [2] Optimizing transfusion management of multiple myeloma patients receiving daratumumab-based regimens
    Phou, Samantha
    Costello, Caitlin
    Kopko, Patricia M.
    Allen, Elizabeth S.
    TRANSFUSION, 2021, 61 (07) : 2054 - 2063
  • [3] Alloimmunization Rates and Transfusion Management of Multiple Myeloma Patients Receiving Daratumumab-Based Regimens
    Phou, Samantha
    Costello, Caitlin
    Kopko, Patricia
    Allen, Elizabeth S.
    TRANSFUSION, 2020, 60 : 223A - 224A
  • [4] Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Schiller, Gary J.
    Callander, Natalie Scott
    Tuchman, Sascha
    Bahlis, Nizar J.
    White, Darrell
    Chen, Christine
    Baljevic, Muhamed
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Bensinger, William
    Rossi, Adriana C.
    Sheehan, Heidi
    Arazy, Melina
    Kai, Kazuharu
    Lipe, Brea
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
    Rikako Tabata
    Nobue Sato
    Nobuhiko Yamauchi
    Yong-Mei Guo
    Hirotaka Nakamura
    Akihito Nagata
    Chi Song-Gi
    Yosuke Minami
    Junichiro Yuda
    Annals of Hematology, 2022, 101 : 465 - 467
  • [6] Effect of Bortezomib Regimens and Daratumumab Monotherapy on Cellular Immunity in Multiple Myeloma Patients
    Kakoo, Ashraf
    Rasheed, Taban
    Al-Attar, Mustafa
    IRANIAN JOURNAL OF IMMUNOLOGY, 2021, 18 (02) : 119 - 129
  • [7] Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
    Tabata, Rikako
    Sato, Nobue
    Yamauchi, Nobuhiko
    Guo, Yong-Mei
    Nakamura, Hirotaka
    Nagata, Akihito
    Chi, Song-Gi
    Minami, Yosuke
    Yuda, Junichiro
    ANNALS OF HEMATOLOGY, 2022, 101 (02) : 465 - 467
  • [8] Infectious risks in newly diagnosed multiple myeloma (NDMM) patients receiving (or treated with) daratumumab based regimens: a multicentric Italian experience
    Rago, Angela
    Fioritoni, Francesca
    Offidani, Massimo
    Annibali, Ombretta
    Poggiali, Roberta
    Za, Tommaso
    Franceschini, Luca
    De Padua, Laura
    Piciocchi, Alfonso
    Fiorini, Alessia
    di Toritto, Tommaso Caravita
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S150 - S150
  • [9] HYPOGAMMAGLOBULINEMIA IN PATIENTS WITH MULTIPLE MYELOMA (MM) TREATED WITH DARATUMUMAB. EXPERIENCE IN A CENTER
    Gonzalo, Benzo
    Beatriz, Aguado
    Isabel, Vicuna
    Carlota, Mayor
    Ana, Puchol
    Sofia, Diaz
    Carmen, Jimenez-Montes
    Ahlam, Serroukh
    Adrian, Alegre
    HAEMATOLOGICA, 2021, 106 (10) : 139 - 139
  • [10] Daratumumab in transplant regimens for myeloma?
    Harousseau, Jean Luc
    Mohty, Mohamad
    BLOOD, 2020, 136 (08) : 917 - 918
12345